rs61751507
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001308.3(CPN1):c.533G>A(p.Gly178Asp) variant causes a missense change. The variant allele was found at a frequency of 0.043 in 1,613,682 control chromosomes in the GnomAD database, including 1,667 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_001308.3 missense
Scores
Clinical Significance
Conservation
Publications
- carboxypeptidase N deficiencyInheritance: AR Classification: LIMITED Submitted by: Illumina, G2P
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -20 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001308.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CPN1 | NM_001308.3 | MANE Select | c.533G>A | p.Gly178Asp | missense | Exon 3 of 9 | NP_001299.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CPN1 | ENST00000370418.8 | TSL:1 MANE Select | c.533G>A | p.Gly178Asp | missense | Exon 3 of 9 | ENSP00000359446.3 |
Frequencies
GnomAD3 genomes AF: 0.0346 AC: 5254AN: 151744Hom.: 131 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.0423 AC: 10647AN: 251480 AF XY: 0.0420 show subpopulations
GnomAD4 exome AF: 0.0438 AC: 64060AN: 1461822Hom.: 1536 Cov.: 32 AF XY: 0.0437 AC XY: 31788AN XY: 727222 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0346 AC: 5255AN: 151860Hom.: 131 Cov.: 31 AF XY: 0.0335 AC XY: 2483AN XY: 74202 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Anaphylotoxin inactivator deficiency Pathogenic:1Benign:1
not specified Benign:1
Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency in ESP (all):461/13006=3.54%
not provided Benign:1
CPN1-related disorder Benign:1
This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at